Provided by Tiger Trade Technology Pte. Ltd.

BioAge Labs Inc.

6.61
-0.2000-2.94%
Post-market: 6.610.00000.00%16:15 EDT
Volume:869.63K
Turnover:5.78M
Market Cap:303.38M
PE:-2.79
High:6.92
Open:6.92
Low:6.47
Close:6.81
52wk High:25.96
52wk Low:5.04
Shares:45.90M
Float Shares:37.58M
Volume Ratio:1.36
T/O Rate:2.31%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-2.3710
EPS(LYR):-2.2432
ROE:-28.21%
ROA:-18.47%
PB:0.81
PE(LYR):-2.95

Loading ...

Analysts Offer Insights on NA Companies: Central Bancompany (CBC) and BioAge Labs, Inc. (BIOA)

TIPRANKS
·
Aug 03

BioAge Labs Price Target Maintained with a $40.00/Share by BTIG

Dow Jones
·
Aug 03

Analysts Have Conflicting Sentiments on These NA Companies: BioAge Labs, Inc. (BIOA) and adidas AG (GB:0OLD)

TIPRANKS
·
Aug 01

Small U.S. Stocks Close Lower; BioAge Labs Posts Biggest Loss

Dow Jones
·
Aug 01

BioAge Labs is Maintained at Buy by Needham

Dow Jones
·
Aug 01

Roth MKM Reaffirms Their Buy Rating on BioAge Labs, Inc. (BIOA)

TIPRANKS
·
Aug 01

Monte Rosa, BioAge sink following Novo Nordisk’s ZEUS setback

TIPRANKS
·
Aug 01

BioAge Labs price target lowered to $25 from $36 at Roth Capital

TIPRANKS
·
Aug 01

Buy Rating Reaffirmed on BioAge: Sell-Off Seen as Overdone Amid Validated NLRP3 Platform and Triple-Digit Upside Potential

TIPRANKS
·
Aug 01

BioAge Labs pullback after ZEUS data ‘seems overdone,’ says Citi

TIPRANKS
·
Aug 01

BioAge Labs price target lowered at Jefferies after Novo trial miss

TIPRANKS
·
Aug 01

BioAge Labs price target lowered to $50 from $60 at Oppenheimer

TIPRANKS
·
Aug 01

BioAge Labs Down over 61%, on Pace for Largest Percent Decrease Since December 2024

Dow Jones
·
Aug 01

U.S. Research ROUNDUP-Apple, Amazon, Mastercard

Reuters
·
Jul 31

Sales of Leqembi® Totaled 29.3 Billion Yen in the Second Quarter 2026

THOMSON REUTERS
·
Jul 29

How Broad Russell Growth Index Inclusion Could Shape BioAge Labs (BIOA) Investor Exposure

Simply Wall St.
·
Jul 10

Bioage Labs Principal Accounting Officer Shane Barton Disposes of 62,566 Common Shares for $1,578,254.20

Reuters
·
Jul 02

BioAge Moves BGE-102 Into Mid-Stage Obesity Heart-Risk Trial, Raising New Investor Focus

TIPRANKS
·
Jun 19

Analysts Are Bullish on These Healthcare Stocks: BioAge Labs, Inc. (BIOA), Karyopharm Therapeutics (KPTI)

TIPRANKS
·
Jun 17

Analysts Offer Insights on Healthcare Companies: BioAge Labs, Inc. (BIOA) and Viridian Therapeutics (VRDN)

TIPRANKS
·
Jun 17